Health ❯ Healthcare ❯ Medical Research ❯ Cancer Treatment

Immunotherapy

Personalized mRNA Vaccine Halves Five‑Year Melanoma Recurrence Risk

Five‑year results show durable drops in metastasis with higher survival, leaving phase 3 confirmation plus manufacturing scale‑up as remaining needs.

Low-Dose Nivolumab Injections Shrink High-Risk Oral Precancers in Early Trial

Immunotherapy Before 3 p.m. Linked to Longer Survival in Small Cell Lung Cancer

mRNA COVID Vaccines Linked to Longer Survival With Cancer Immunotherapy, Nature Study Reports

mRNA COVID Vaccines Linked to Longer Survival With Checkpoint Immunotherapy, Peer‑Reviewed Study Finds

Cambridge Researchers Demonstrate Tumor-Triggered Two-Part STING Prodrug

Pumitamig Shows High Response in First-Line Small Cell Lung Cancer Phase 2

UCLA Details Off-the-Shelf CAR-NKT Therapy With Preclinical Success in Metastatic Kidney Cancer

TIM‑3 Triplet Therapy Shows Promise in Immunotherapy‑Resistant Melanoma Models

mRNA Neoantigen Vaccine Amplifies Anti-PD-1 Immunity and Suppresses Gastric Cancer Spread in Mice

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

Researchers Plan Trials to Counteract Sucralose’s Impairment of Cancer Immunotherapy

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma

High-Dose Steroids Undermine Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors